Boston Partners’s Bausch Health BHC Stock Holding History

Boston Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61,447	Closed	-$1.7M	–	702
2021 Q4	$1.7M	Hold	61,447	–	–	﹤0.01%	475
2021 Q3	$1.71M	Sell	61,447 -8,852	-13%	-$251K	﹤0.01%	468
2021 Q2	$2.06M	Sell	70,299 -1,499	-2%	-$45.4K	﹤0.01%	458
2021 Q1	$2.28M	Sell	71,798 -52,906	-42%	-$1.55M	﹤0.01%	465
2020 Q4	$2.59M	Sell	124,704 -11,019	-8%	-$206K	﹤0.01%	407
2020 Q3	$2.11M	Sell	135,723 -4,167	-3%	-$71.8K	﹤0.01%	415
2020 Q2	$2.56M	Sell	139,890 -84,275	-38%	-$1.48M	﹤0.01%	398
2020 Q1	$3.48M	Buy	+224,165	New	+$5.41M	0.01%	385

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

GCC

Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Boston Partners's BHC Position: Q1 2022 in Review

Boston Partners sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 61,447 shares — an estimated $1.7M sold.

Boston Partners first reported a position in BHC in Q1 2020 and held it in 8 quarters. The position peaked at $3.48M in Q1 2020. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

Boston Partners reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
Boston Partners sold 61,447 Bausch Health shares in Q1 2022, an estimated $1.7M.
Boston Partners first reported a position in Bausch Health in Q1 2020 and held it in 8 quarters.
Boston Partners's Bausch Health position peaked at $3.48M in Q1 2020.
370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.